Rationale and Objectives-To determine the accuracy and sensitivity for dual-energy computed tomography (DECT) discrimination of uric acid (UA) stones from other (non-UA) renal stones in a commercially implemented product.Materials and Methods-Forty human renal stones comprising uric acid (n = 16), hydroxyapatite (n = 8), calcium ox-alate (n = 8), and cystine (n = 8) were inserted in four porcine kidneys (10 each) and placed inside a 32-cm water tank anterior to a cadaver spine. Spiral dual-energy scans were obtained on a dual-source, 64-slice computed tomography (CT) system using a clinical protocol and automatic exposure control. Scanning was performed at two different collimations (0.6 mm and 1.2 mm) and within three phantom sizes (medium, large, and extra large) resulting in a total of six image datasets. These datasets were analyzed using the dual-energy software tool available on the CT system for both accuracy (number of stones correctly classified as either UA or non-UA) and sensitivity (for UA stones). Stone characterization was correlated with micro-CT.Results-For the medium and large phantom sizes, the DECT technique demonstrated 100% accuracy (40/40), regardless of collimation. For the extra large phantom size and the 0.6-mm collimation (resulting in the noisiest dataset), three (two cystine and one small UA) stones could not be classified (93% accuracy and 94% sensitivity). For the extra large phantom size and the 1.2-mm collimation, the dual-energy tool failed to identify two small UA stones (95% accuracy and 88% sensitivity). Conclusions-In an anthropomorphic phantom model, dual-energy CT can accurately discriminate uric acid stones from other stone types. KeywordsKidney stones; renal calculi; dual-energy computed tomography; uric acid; urolithiasis Symptomatic urinary stone disease affects approximately 900,000 persons in the United States each year, resulting in annual medical cost of $5.3 billion. Nephrolithiasis has traditionally been evaluated using plain film radiographic techniques with or without tomography or administration of intravenous contrast for excretory urography. Over recent years, however, computed tomography (CT) has supplanted these traditional techniques because of increased sensitivity, speed, and the lack of intravenous contrast (1 Although state-of-the-art CT provides accurate submillimeter details of the size and location of renal stones (4,5), current routine clinical image analysis does not differentiate stone composition. This is particularly important in the case of uric acid (UA) stones (~10% of cases), because urinary alkalinization can be prescribed to dissolve UA stones and could thereby be initiated at presentation rather than following lengthy metabolic workup. Therefore simple and reliable differentiation of UA versus non-UA stone composition could potentially allow patients with UA stones to avoid invasive interventional urinary procedures for stone removal or external shock wave lithotripsy, both of which are expensive and might result in renal hemorrh...
COM stones are often resistant to breakage using shock wave (SW) lithotripsy. It would be useful to identify by computed tomography (CT) those COM stones that are susceptible to SW's. For this study, 47 COM stones (4-10 mm in diameter) were scanned with micro CT to verify composition and also for assessment of heterogeneity (presence of pronounced lobulation, voids, or apatite inclusions) by blinded observers. Stones were then placed in water and scanned using 64-channel helical CT. As with micro CT, heterogeneity was assessed by blinded observers, using high-bone viewing windows. Then stones were broken in a lithotripter (Dornier Doli-50) over 2 mm mesh, and SW's counted. Results showed that classification of stones using micro CT was highly repeatable among observers (κ=0.81), and also predictive of stone fragility. Stones graded as homogeneous required 1874±821 SW/g for comminution, while stones with visible structure required half as many SW/g, 912±678. Similarly, when stones were graded by appearance on helical CT, classification was repeatable (κ=0.40), and homogeneous stones required more SW's for comminution than did heterogeneous stones (1702±993 SW/g, compared to 907±773). Stone fragility normalized to stone size did not correlate with Hounsfield units (p=0.85). In conclusion, COM stones of homogeneous structure require almost twice as many SW's to comminute than stones of similar mineral composition that exhibit internal structural features that are visible by CT. This suggests that stone fragility in patients could be predicted using pre-treatment CT imaging. The findings also show that Hounsfield unit values of COM stones did not correlate with stone fragility. Thus, it is stone
Apatite and brushite kidney stones share calcium and phosphate as their main inorganic components. We tested the hypothesis that these stone types differ in the organic matrix present in the stones. Intact stones were intensively analyzed by micro-computed tomography (micro CT) for both morphology (including the volume of voids, i.e., regions without mineral) and mineral type. In order to extract all proteins present in kidney stones in soluble form we developed a three-step extraction procedure using the ground stone powder. Apatite stones had significantly higher levels of total protein content and void volume compared to brushite stones. The void volume was highly correlated with the total protein contents in all stones (r2=0.61, P<0.0001), and brushite stones contained significantly fewer void regions and proteins than did apatite stones (3.2±4.5% voids for brushite vs. 10.8±11.2% for apatite, P<0.005; 4.1±1.6% protein for brushite vs. 6.0±2.4% for apatite, P<0.03). Morphological observations other than void volume did not correlate with protein content of stones, and neither did the presence or absence of minor mineral components. Our results show that protein content of brushite and apatite stones is higher than was previously thought, and also suggest that micro CT-visible void regions are related to the presence of protein.
INTRODUCTION The goal of this study was to determine the accuracy of stone composition analysis by commercial laboratories. METHODS 25 human renal stones with infrared spectroscopy (IR) determined compositions were fragmented into aliquots and studied with micro-computed tomography (CT) to ensure fragment similarity. Representative fragments of each stone were submitted to 5 commercial stone laboratories for blinded analysis. RESULTS All laboratories agreed on composition for 6 pure stones. Of 4 stones known to contain struvite, only 2(50%) were identified as struvite by all laboratories. Struvite was reported as a component by some laboratories for 4 stones previously determined not to contain struvite. Overall, there was disagreement regarding struvite in 6(24%) stones. For 9 calcium oxalate (CaOx) stones, all laboratories reported some mixture of CaOx, but the quantities of subtypes differed significantly among laboratories. In 6 apatite containing stones, apatite was missed by the laboratories in 20% of the samples. None of the laboratories identified atazanavir in a stone containing that antiviral drug. One laboratory reported protein in every sample, while all others reported it in only 1 sample. Nomenclature for apatite differed among laboratories, with one reporting apatite as carbonate apatite (CA) and never hydroxyapatite (HA), another never reporting CA and always reporting HA, and a third reporting CA as apatite with calcium carbonate. CONCLUSIONS Commercial laboratories reliably recognize pure calculi; however, variability in reporting of mixed calculi suggests a problem with accuracy of stone analysis results. Furthermore, there is a lack of standard nomenclature used by laboratories.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.